Observational studyItalian journal of pediatrics2026

Real-world effectiveness of nirsevimab against respiratory syncytial virus in pediatric practice: the Piemonitorab study.

Elisa Funiciello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.